SCHEMBL4335673

SCHEMBL4335673

COc1ccccc1-c1cnc(N)nc1N

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.56
LRRK2 Q5S007 1/20 0.53
ALDH1A1 P00352 2/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ADORA1 P30542 3/20 0.49
HSP90AA1 P07900 2/20 0.49
JAK2 O60674 1/20 0.49
PDGFRB P09619 1/20 0.48
FGFR1 P11362 1/20 0.48
SRC P12931 1/20 0.48
PDGFRA P16234 1/20 0.48
ADORA2A P29274 3/20 0.48
HSP90AB1 P08238 1/20 0.48
P2RX3 P56373 2/20 0.47
P2RX2 Q9UBL9 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4484811 0.86 DHFR (0.56) DHFRLRRK2ADORA1HSP90AA1FGFR1
SCHEMBL28337754 0.86 DHFR (0.52) DHFRALDH1A1GAA
SCHEMBL8129903 0.85 FGFR1 (0.59) DHFRLRRK2ALDH1A1GAAMAPT
SCHEMBL12813225 0.84 HSP90AA1 (0.49) DHFRLRRK2ALDH1A1GAAHSP90AA1
SCHEMBL27612564 0.81 ADORA1 (0.61) DHFRADORA1ADORA2AP2RX3P2RX2
SCHEMBL1388631 0.80 DHFR (0.56) DHFRALDH1A1MAPTFGFR1P2RX3
SCHEMBL28815326 0.80 SCN10A (0.49) DHFRP2RX3P2RX2
SCHEMBL30488023 0.80 DHFR (0.56) DHFRALDH1A1MAPTFGFR1P2RX3
SCHEMBL1614076 0.78 DHFR (0.55) DHFRGAAMAPTNPSR1ADORA1
SCHEMBL1613741 0.78 DHFR (0.55) DHFRADORA1ADORA2AP2RX3P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2136635-A1 CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2009-12-30 EP claimed
WO-2008115738-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-09-25 WO claimed
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 CN disclosed
CN-110325516-A HETEROARYL COMPOUNDS AND THEIR USE 米尼奥尔克斯治疗有限公司 2019-10-11 CN disclosed
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed